Recent Quotes

My Watchlist

Indicators

Latest News about NYSE:MRK

Recent news which mentions NYSE:MRK

< Previous 1 2 3 4 5 6 7 8 Next >

5 Defensive Stocks to Own for Consistent Dividends and Stable Earnings

February 24, 2022

3 Wide-Moat Stocks to Withstand a Market Downturn: Microsoft, Merck, and Blackbaud

February 24, 2022

Why This New Dad Says Every Company Should Offer Parental Leave

February 23, 2022

Stabilize Your Portfolio with These 5 High-Quality Stocks

February 18, 2022

Is Canopy Growth a Smart Cannabis Stock to Own in 2022?

February 17, 2022

Paying Tribute to Our Black Leaders in Science

February 09, 2022

This Leader Works To Ensure Diversity and Inclusion Is Visible in Everything We Do

February 04, 2022

Giving Back: How Our Pro Bono Program Drives Positive Change

February 02, 2022

3 Top Dow Jones Stocks to Safeguard Your Portfolio

January 27, 2022

Our Disability Inclusiveness Earns Top Employer Award

January 26, 2022

Merck Scientists Launch Research Award to Support Rising Chemists of Color

January 19, 2022

Catalyst Pharmaceuticals: A Biotech Stock Worth Owning

January 18, 2022

Merck and Ridgeback Announce Supply Agreement With UNICEF for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine

January 18, 2022

Is electroCore a Good Stock to Add to Your Healthcare Portfolio?

January 14, 2022

A Nobel Prize for a Longtime Merck Collaborator

January 14, 2022

The 3 Best S&P 500 High Yield Dividend Stocks For 2022

January 12, 2022

2 Dividend Growth Stocks to Add to Your Income Portfolio in January

January 12, 2022

Does Teva Pharmaceutical Deserve a Place in Your 2022 Portfolio?

January 12, 2022

Better Buy for 2022: Merck vs. AstraZeneca

January 11, 2022

Is Now a Good Time to Scoop Up Shares of Canopy Growth?

January 11, 2022

Merck Announces Additional $150M Investment Through 2025 to Help End Maternal Mortality Inequities

January 10, 2022

Down 70% in 2021, is Now a Good Time to Scoop Up Shares of TherapeuticsMD?

January 07, 2022

Introducing the 2022 Dogs of the Dow: 10 High-Yield Blue Chips Paying up to 4.9%

January 07, 2022

How Merck Is Prioritizing Supply

January 07, 2022

Showing Our Gratitude: Addressing COVID-19 Takes a Global Effort

January 05, 2022

4 Drug Manufacturing Stocks to Add to Your Dividend Portfolio in January

December 28, 2021

Merck and Ridgeback's Molnupiravir Receives U.S. FDA Emergency Use Authorization for the Treatment of High-Risk Adults With Mild to Moderate COVID-19

December 28, 2021

When the COVID-19 Pandemic Hit, Our Cafeterias Stepped up To Serve People in Need

December 20, 2021

Merck and Ridgeback Announce Publication of Phase 3 Study of Molnupiravir, an Investigational Oral Antiviral COVID-19 Treatment, in the New England Journal of Medicine

December 17, 2021

Merck Issues $1 Billion Inaugural Sustainability Bond

December 13, 2021

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Search Hotels in Sausalito

Find A Business

or Browse Listings

Latest News about NYSE:MRK